Dataset Information


Combination of cytokine responses indicative of latent TB and active TB in Malawian adults.

ABSTRACT: An IFN-? response to M. tuberculosis-specific antigens is an effective biomarker for M. tuberculosis infection but it cannot discriminate between latent TB infection and active TB disease. Combining a number of cytokine/chemokine responses to M. tuberculosis antigens may enable differentiation of latent TB from active disease.Asymptomatic recently-exposed individuals (spouses of TB patients) were recruited and tuberculin skin tested, bled and followed-up for two years. Culture supernatants, from a six-day culture of diluted whole blood samples stimulated with M. tuberculosis-derived PPD or ESAT-6, were measured for IFN-?, IL-10, IL-13, IL-17, TNF-? and CXCL10 using cytokine ELISAs. In addition, 15 patients with sputum smear-positive pulmonary TB were recruited and tested.Spouses with positive IFN-? responses to M. tuberculosis ESAT-6 (>62.5 pg/mL) and TB patients showed high production of IL-17, CXCL10 and TNF-?. Higher production of IL-10 and IL-17 in response to ESAT-6 was observed in the spouses compared with TB patients while the ratios of IFN-?/IL-10 and IFN-?/IL-17 in response to M. tuberculosis-derived PPD were significantly higher in TB patients compared with the spouses. Tuberculin skin test results did not correlate with cytokine responses.CXCL10 and TNF-? may be used as adjunct markers alongside an IFN-? release assay to diagnose M. tuberculosis infection, and IL-17 and IL-10 production may differentiate individuals with LTBI from active TB.


PROVIDER: S-EPMC3832606 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6788090 | BioStudies
2014-01-01 | S-EPMC4280211 | BioStudies
2020-01-01 | S-EPMC7459825 | BioStudies
2009-01-01 | S-EPMC2671601 | BioStudies
2014-01-01 | S-EPMC3910933 | BioStudies
2013-01-01 | S-EPMC3653866 | BioStudies
1000-01-01 | S-EPMC2643222 | BioStudies
2015-01-01 | S-EPMC4446217 | BioStudies
2019-01-01 | S-EPMC6830137 | BioStudies
2018-01-01 | S-EPMC5845669 | BioStudies